ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Emery, R. W.
Right arrow Articles by Pritzker, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Emery, R. W.
Right arrow Articles by Pritzker, M. R.

The Annals of Thoracic Surgery, Vol 53, 282-288, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Experience with the symbion total artificial heart as a bridge to transplantation

RW Emery, LD Joyce, M Prieto, K Johnson, IF Goldenberg and MR Pritzker
Division of Mechanical Circulatory Support, Minneapolis Heart Institute, Minnesota.

From December 1985 through January 1991, 9 patients underwent bridging to transplantation using a Symbion J-7-70 total artificial heart. There were 4 female and 5 male patients aged 31 +/- 14 years (range, 15 to 52 years). Five patients were supported on an intraaortic balloon pump before total artificial heart support, and 2 had biventricular assist devices as well. Total artificial heart support was maintained for 17 +/- 12 days (range, 4 to 44 days); all patients underwent transplantation. Three patients died after transplantation on day 0 (primary donor organ failure), 25 (acute rejection), and 256 (multiorgan failure). The remainder were discharged at 41 +/- 32 days (range, 13 to 101 days). One patient died 28 months after transplantation of late acute rejection. Actuarial 1-year and 3-year survival is 67% and 55%. There were no surgical wound infections. Problems encountered in the J-7-70 period and the period after transplantation were for the most part related to patient condition in the period before implantation. The Symbion J-7-70 total artificial heart is an effective device for total circulatory support in patients with end-stage cardiogenic shock when an organ donor is not available. Organ system failure and infection before implantation may persist into the transplantation period resulting in long-term complications, increased mortality, and prolonged hospital stay; therefore, early implantation of the device when indicated should be applied.


This article has been cited by other articles:


Home page
PerfusionHome page
A. El-Banayosy, H. Posival, K. Minami, L. Arusoglu, L. Kizner, T. Breymann, D. Seifert, M. Korner, H. Kortke, O. Fey, et al.
Mechanical circulatory support: lessons from a single centre
Perfusion, March 1, 1996; 11(2): 93 - 102.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. N. Nanas, C. T. Lolas, C. E. Charitos, S. N. Nanas, Z. J. Margari, E. V. Agapitos, and S. D. Moulopoulos
A VAVLELESS HIGH STROKE VOLUME COUNTERPULSATION DEVICE RESTORES HEMODYNAMICS IN PATIENTS WITH CONGESTIVE HEART FAILURE AND INTRACTABLE CARDIOGENIC SHOCK AWAITING HEART TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 55 - 61.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. Korfer, A. El-Banayosy, H. Posival, K. Minami, L. Kizner, L. Arusoglu, and M. M. Korner
Mechanical Circulatory Support With the Thoratec Assist Device in Patients With Postcardiotomy Cardiogenic Shock
Ann. Thorac. Surg., January 1, 1996; 61(1): 314 - 316.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.